196 related articles for article (PubMed ID: 28494415)
1. Studies on curative efficacy of monoterpene eugenol on anti- leukemic drug arsenic trioxide induced cardiotoxicity.
Binu P; Priya N; Abhilash S; Vineetha RC; Nair RH
Biomed Pharmacother; 2017 Jul; 91():559-566. PubMed ID: 28494415
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of arsenic trioxide induced cardiotoxicity through flaxseed oil in experimental rats.
Varghese MV; Abhilash M; Alex M; Paul MVS; Prathapan A; Raghu KG; Nair RH
Redox Rep; 2017 Nov; 22(6):346-352. PubMed ID: 28209094
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 Fatty Acid Protects Against Arsenic Trioxide-Induced Cardiotoxicity In Vitro and In Vivo.
Varghese MV; Abhilash M; Paul MV; Alex M; Nair RH
Cardiovasc Toxicol; 2017 Apr; 17(2):109-119. PubMed ID: 26886836
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat.
Hemmati AA; Olapour S; Varzi HN; Khodayar MJ; Dianat M; Mohammadian B; Yaghooti H
Hum Exp Toxicol; 2018 Apr; 37(4):412-419. PubMed ID: 28474970
[TBL] [Abstract][Full Text] [Related]
5. Eugenol, a plant-derived phenolic nutraceutical, protects thiol (SH) group in myocardium from ROS-mediated oxidation under chemotherapeutic stress induced by arsenic trioxide - a in vivo model study.
Binu P; Gifty K; Vineetha RC; Abhilash S; Arathi P; Nair RH
Drug Chem Toxicol; 2018 Jul; 41(3):352-357. PubMed ID: 29372663
[TBL] [Abstract][Full Text] [Related]
6. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
7. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide.
Mathews VV; Paul MV; Abhilash M; Manju A; Abhilash S; Nair RH
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():34-8. PubMed ID: 23436664
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia drug - arsenic trioxide in the presence of eugenol shows differential action on leukemia cells (HL-60) and cardiomyocytes (H9c2) - inference from NMR study.
Binu P; Soman R; Zakhariah Hisham O; Narayanan SP; Nair RH
Toxicol Mech Methods; 2021 Jul; 31(6):457-466. PubMed ID: 33879037
[TBL] [Abstract][Full Text] [Related]
9. Cardiac toxicity of arsenic trioxide.
Barbey JT
Blood; 2001 Sep; 98(5):1632; author reply 1633-4. PubMed ID: 11547771
[No Abstract] [Full Text] [Related]
10. Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats.
Saad SY; Alkharfy KM; Arafah MM
J Pharm Pharmacol; 2006 Apr; 58(4):567-73. PubMed ID: 16597375
[TBL] [Abstract][Full Text] [Related]
11. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide.
Unnikrishnan D; Dutcher JP; Varshneya N; Lucariello R; Api M; Garl S; Wiernik PH; Chiaramida S
Blood; 2001 Mar; 97(5):1514-6. PubMed ID: 11222403
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.
Ohnishi K; Yoshida H; Shigeno K; Nakamura S; Fujisawa S; Naito K; Shinjo K; Fujita Y; Matsui H; Takeshita A; Sugiyama S; Satoh H; Terada H; Ohno R
Ann Intern Med; 2000 Dec; 133(11):881-5. PubMed ID: 11103058
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity.
Fouad AA; Yacoubi MT
Arch Pharm Res; 2011 May; 34(5):821-8. PubMed ID: 21656368
[TBL] [Abstract][Full Text] [Related]
15. Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis.
Fan Y; Wang C; Zhang Y; Hang P; Liu Y; Pan Z; Wang N; Du Z
Cell Physiol Biochem; 2013; 31(1):80-91. PubMed ID: 23363563
[TBL] [Abstract][Full Text] [Related]
16. Complete atrioventricular block after arsenic trioxide treatment in an acute promyelocytic leukemic patient.
Huang CH; Chen WJ; Wu CC; Chen YC; Lee YT
Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):965-7. PubMed ID: 10392399
[TBL] [Abstract][Full Text] [Related]
17. Cardiac toxicity of arsenic trioxide.
Singer JW
Blood; 2001 Sep; 98(5):1633; author reply 1633-4. PubMed ID: 11547772
[No Abstract] [Full Text] [Related]
18. Effect and mechanism of Sorbus pohuashanensis (Hante) Hedl. flavonoids protect against arsenic trioxide-induced cardiotoxicity.
Yu X; Wang Z; Shu Z; Li Z; Ning Y; Yun K; Bai H; Liu R; Liu W
Biomed Pharmacother; 2017 Apr; 88():1-10. PubMed ID: 28092839
[TBL] [Abstract][Full Text] [Related]
19. Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.
Ducas RA; Seftel MD; Ducas J; Seifer C
J R Coll Physicians Edinb; 2011 Jun; 41(2):117-8. PubMed ID: 21677914
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Eugenol against Hepatotoxicity Induced by Arsenic Trioxide: An Antileukemic Drug.
Binu P; Priya N; Abhilash S; Vineetha RC; Nair H
Iran J Med Sci; 2018 May; 43(3):305-312. PubMed ID: 29892148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
